Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination drug is a local anesthetic cocktail used for regional anesthesia, specifically for ultrasound-guided fascia-iliaca blocks in patients undergoing hip arthroscopy. It consists of ropivacaine, a long-acting amide-type local anesthetic that inhibits sodium ion influx in nerve fibers; clonidine, an alpha-2 adrenergic agonist that acts as an analgesic adjuvant to prolong the duration of the block; and epinephrine, a vasoconstrictor that reduces systemic absorption and extends the local effect. The Hawkins Foundation is evaluating this combination in a Phase 4 clinical trial to compare its efficacy against standard local anesthetic injections for managing post-operative pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ropivacaine + clonidine + epinephrine (The Hawkins Foundation).